A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia
Clinical trial NCT01258920 · COMPLETED
Trial details
- NCT number
- NCT01258920
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-11-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.